Patents by Inventor Scott Hagerman

Scott Hagerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10869843
    Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: December 22, 2020
    Assignee: CHEMI NUTRA
    Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jager
  • Publication number: 20120141448
    Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
    Type: Application
    Filed: November 23, 2011
    Publication date: June 7, 2012
    Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jäger
  • Patent number: 6525027
    Abstract: Ribose administered to humans performing weight-training exercise provides more rapid increase in muscle mass and decrease in body fat than weight-training exercise without ribose.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: February 25, 2003
    Assignee: Bioenergy Inc.
    Inventors: Lou Vazquez, Scott Hagerman, Terri L. Butler
  • Patent number: 6429198
    Abstract: Pentose is administered to mammals to increase athletic performance and reduce fatigue.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: August 6, 2002
    Assignee: Bioenergy Inc.
    Inventors: John St. Cyr, Clarence A. Johnson, Scott Hagerman, Louis W. Vasquez, Terri L. Butler
  • Publication number: 20020035069
    Abstract: Ribose administered to humans performing weight-training exercise provides more rapid increase in muscle mass and decrease in body fat than weight-training exercise without ribose.
    Type: Application
    Filed: January 19, 2001
    Publication date: March 21, 2002
    Inventors: Lou Vazquez, Scott Hagerman, Terri L. Butler